BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19131789)

  • 21. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
    Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
    Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
    Krackhardt A; Schwartz S; Korfel A; Thiel E
    Leuk Lymphoma; 1999 Nov; 35(5-6):631-5. PubMed ID: 10609804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity.
    Chan WK; Hui WF
    Pediatr Nephrol; 2016 Oct; 31(10):1699-703. PubMed ID: 27335061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
    Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe methotrexate toxicity precipitated by intravenous radiographic contrast.
    Harned TM; Mascarenhas L
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):496-9. PubMed ID: 17609630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced methotrexate clearance and renal impairment in a boy with osteosarcoma and earlier undetected autosomal dominant polycystic kidney disease (ADPKD).
    Alberer M; Hoefele J; Bergmann C; Hartrampf S; Hilberath J; Pawlita I; Albert MH; Benz MR; Weber LT; Schmid I
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e314-6. PubMed ID: 20921908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary.
    Milone MC
    Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
    Yamada K; Takahashi M; Yoshida M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature.
    Perez-Verdia A; Angulo F; Hardwicke FL; Nugent KM
    Pharmacotherapy; 2005 Sep; 25(9):1271-6. PubMed ID: 16164401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary.
    Fox E; Balis FM
    Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
    [No Abstract]   [Full Text] [Related]  

  • 32. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
    Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
    Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.
    Pugi A; Benemei S; Vietri M; Tondo A; Calvani AM; Mugelli A; Vannacci A; Lapi F
    J Clin Pharm Ther; 2012 Apr; 37(2):245-8. PubMed ID: 21569069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
    Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
    Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
    Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
    [No Abstract]   [Full Text] [Related]  

  • 36. High-dose methotrexate-doxycycline interaction.
    Tortajada-Ituren JJ; Ordovás-Baines JP; Llopis-Salvia P; Jiménez-Torres NV
    Ann Pharmacother; 1999; 33(7-8):804-8. PubMed ID: 10466909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].
    von Poblozki A; Dempke W; Schmoll HJ
    Med Klin (Munich); 2000 Aug; 95(8):457-60. PubMed ID: 10985069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing and Managing Toxicities of High-Dose Methotrexate.
    Howard SC; McCormick J; Pui CH; Buddington RK; Harvey RD
    Oncologist; 2016 Dec; 21(12):1471-1482. PubMed ID: 27496039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Compatibility and toxicity of methotrexate in the treatment of bone tumors].
    Pongracz N; Kelaridis T; Ritschl P
    Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R; Rentsch K; Di Paolo E; Popovic MB
    Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.